| Oncogenic activation of the WNT/beta-catenin signaling pathway is common in hepatocellular carcinoma. | liver, |
| Activated embryonal development-related wnt1/beta-catenin pathway might take part in the oncogenesis and growth of neural crest-derived neuroblastoma. | neuroblastoma, |
| Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. | brain, |
| The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. | brain, |
| The INT1 oncogene is not rearranged or amplified in lipomas with structural chromosomal abnormalities of 12q13-15. | lipoma, |
| Amplification of the human putative oncogene INT1 in primary retinoblastoma tumors. | retinoblastoma, |
| [The Wnt1 oncogene: from mice mammary tumors to human tumors (continuation)]. | None |
| Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland. | None |
| Mammary stem cells and/or progenitors to mammary luminal epithelial and myoepithelial cells may be the targets for oncogenesis by Wnt-1. | None |
| Data suggest that c-MYC and Wnt1 select for the outgrowth of cells with mutations in specific ras isoforms such as Kras2, and that these mutations determine the extent of ras/MAPK pathway activation and the potential for oncogene-independent growth. | None |
| The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus. | None |
| Lrp5-mediated canonical signaling is required for mammary ductal stem cell activity and for tumor development in response to oncogenic Wnt effectors. | None |
| Swaying is a mutant allele of the proto-oncogene Wnt-1. | None |
| The proto-oncogene int-1 encodes a secreted protein associated with the extracellular matrix. | None |
| Inhibition of the BCL9-beta-catenin interaction and selectively suppresses oncogenic Wnt transcription. | None |
| int-1--a proto-oncogene involved in cell signalling. | None |
| in the absence of retinoid signaling via RARbeta, reduced IGF-1 signaling results in suppression of epithelial-mesenchymal transition and delays tumorigenesis induced by the Wnt1 oncogene | None |
| Transient expression of the proto-oncogene int-1 during differentiation of P19 embryonal carcinoma cells. | None |
| Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. | None |
| Data indicate that Wnt1 proto-oncogene protein (WNT1) is the direct target of microRNA miR-34a in dendritic cell (DC). | None |